Biondi Paul 4
4 · Seres Therapeutics, Inc. · Filed Apr 8, 2024
Insider Transaction Report
Form 4
Biondi Paul
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-04-04+60,000→ 60,000 totalExercise: $0.76Exp: 2034-04-03→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders.